Growth hormone response to the insulin tolerance and clonidine tests in type 1 diabetes

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 59, Issue 5, 1999, Pages 375-382

  Almqvist, Erik G ^a   Groop, L C ^b   Manhem, P J ^b  

^a Department of Medicine ^*  (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood glucose; C peptide; Hypoglycaemia; Metabolic control; Pituitary; Provocative tests

Indexed keywords

CLONIDINE; GROWTH HORMONE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TOLERANCE TEST; MALE; METABOLIC REGULATION; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; CLONIDINE; DIABETES MELLITUS, TYPE 1; FEMALE; GROWTH HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; RADIOIMMUNOASSAY;

EID: 0032855115     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519950185571     Document Type: Article

References (36)

1. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on adult growth hormone deficiency. J Clin Endocrinol Metab 1998; 83: 379-81.
2. Frier BM, Fisher BM, Gray CE, Beastall GH. Counterregulatory hormonal responses to hypoglycemia in type I (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion. Diabetologia 1988; 31: 421-9.
3. Hirsch BR, Shamoon H, Defective epinephrine and growth hormone responses in type 1 diabetes are stimulus specific. Diabetes 1987; 36: 20-6.
4. Polonsky K, Bergenstal R, Pons G, Schneider M, Jaspan I. Rubenstein A. Relation of counterregulatory responses to hypoglycemia in type 1 diabetics. N Engl J Med 1982; 307: 1106-12.
5. Bolli G, De Feo P, De Cosmo S, Perriello G, Angeletti G, Ventura MR, et al. Effects of long-term optimization and short-term deterioration of glycemic control on glucose counterregulation in type 1 diabetes mellitus. Diabetes 1984; 33: 394-400.
6. Shilo S, Shamoon H. Abnormal growth hormone responses to hypoglycemia and exercise in adults with type 1 diabetes. Isr J Mcd Sci 1990; 26: 136-41.
7. Johansen K, Hansen AP. Diurnal serum growth hormone levels in poorly and well-controlled juvenile diabetics. Diabetes 1971; 20: 239-45.
8. Asplin CM, Faria ACS, Carlsen EC, Vaccaro VA, Barr RE, Iranmanesh A, et al. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1989; 69: 239-45.
9. Hayford JT, Danney MM, Hendrix JA, Thompson RG. Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes 1980; 29: 391-8.
10. Hansen AP. Abnormal serum growth hormone response to exercise in juvenile diabetics. J Clin Invest 1970; 49: 1467-78.
11. Lorenzi M, Karam JH, McIlroy MB, Forsham PH. Increased growth hormone response to dopamine infusion in insulin-dependent diabetic subjects. J Clin Invest 1980; 65: 146-53.
12. Burday SZ, Fine PH, Schalch DS. Growth hormone secretion in response to arginine infusion in normal and diabetic subjects: relationship to blood glucose levels. J Lab Clin Med 1968; 71: 897-911.
13. Topper E, Gertner J, Amiel S, Press M, Genel M, Tamborlane WV. Deranged a-adrenergic regulation of growth hormone secretion in poorly controlled diabetes: reversal of the exaggerated response to clonidine after continuous subcutaneous insulin infusion. Pediatr Res 1985; 19: 534-6.
14. Dasmahapatra A, Urdanivia E, Cohen MP. Growth hormone response to thyrotropin-releasing hormone in diabetes. J Clin Endocrinol Metab 1981; 52: 859-62.
15. Giampietro O, Miccoli R, Ferdeghini M, Penno G, Masoni A, Navalesi R. Inappropriate growth hormone response to luteinizing hormone-releasing hormone in diabetes mellitus. Metabolism 1987; 36: 1149-53.
16. Krassowski J, Felber JP, Rogala H, Jeske W, Zgliczynski S. Exaggerated growth hormone response to growth hormone-releasing hormone in type 1 diabetes mellitus. Acta Endocrinol (Copenh) 1988; 117: 225-9.
17. Speroni G, Ceda GP, Capretti L, Valenti G. Clonidine and GH secretion in insulin dependent diabetes (IDD). Horm Metab Res 1983; 15: 46-7.
18. Giampietro O, Ferdeghini M, Miccoli R, Locatelli V, Cerri M, Yanaihara N, et al. Effect of growth hormone-releasing hormone and clonidine on growth hormone release in type 1 diabetic patients. Horm Metab Res 1987; 19: 636-41.
19. Sundkvist G, Almér L-O, Lilja B. Respiratory influence on heart rate in diabetes mellitus. Br Med J 1979; 1: 924-5.
20. Sundkvist G, Lilja B, Almer L-O. Abnormal diastolic blood pressure and heart rate reactions to tilting in diabetes mellitus. Diabetologia 1980; 19: 433-8.
21. Landin Olsson M, Sundkvist G, Lernmark Å. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 327-32.
22. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990; 300: 230-5.
23. Benzo CA. Minireview. The hypothalamus and blood glucose regulation. Life Sci 1982; 32: 2509 15.
24. Thorner MO, Vance ML, Horvath E, Kovacs K. The anterior pituitary; dynamic test of pituitary function In: Wilson JD, Foster DW, editors. Williams textbook of endocrinology, 8th edition. Philadelphia: WB Saunders: 252-3.
25. Landon J, Greenwood FC, Stamp TCB, Wynn V. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. J Clin Invest 1966; 45: 437-49.
26. Greenwood FC, Landon J, Stamp TCB. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. 1. In control subjects. J Clin Invest 1966, 45: 429-36.
27. Krulich L, Mayfield MA, Steele MK, McMillen BA, McCann SM, Koenig JL. Differential effects of pharmacological manipulations of central alpha-1- and alpha-2-adrenergic receptors on the secretion of thyrotropin and growth hormone in male rats. Endocrinology 1982; 110: 796-804.
28. Ghigo E, Arvat E, Nicolosi M, Bellone J, Valetto MR, Mazza E, et al. Acute clonidine administration potentiates spontaneous diurnal, but not nocturnal, growth hormone secretion in normal short children. J Clin Endocrinol Metab 1990; 71: 433-5.
29. Alba-Roth J, Losa M, Spiess Y, Schopohl J, Müller OA, von Werder K. Interaction of clonidine and GHRH on GH secretion in vivo and in vitro. Clin Endocrinol (Oxf) 1989; 30: 485-91.
30. Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-Dopa, and clonidine-induced GH secretion in normal subjects. J Clin Endocrinol Metab 1996; 81: 1952-5.
31. Jacobs ML, Nathoe HMW, Blankestijn PJ, Stijnen Th, Weber RFA. Growth hormone responses to growth hormone-releasing hormone and clonidine in patients with type 1 diabetes and in normal controls: effect of age, body mass index and sex. Clin Endocrinol (Oxf) 1996; 44: 547-53.
32. Stewart PM, Smith S, Seth J, Stewart SE, Cole D, Edwards CR. Normal growth hormone response to the 75 g oral glucose tolerance test measured by immunoradiometric assay. Ann Clin Biochem 1989; 26: 205-6.
33. Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane WV. Effect of diabetes and its control on insulin-like growth factors in the young subjects with type 1 diabetes. Diabetes 1984; 33: 1175-9.
34. Tan K, Baxter RC. Serum insulin-like growth factor 1 levels in adult diabetic patients: the effect of age. J Clin Endocrinol Metab 1986; 63: 651-5.
35. Sönksen PH, Russel-Jones D, Jones RH. Growth hormone and diabetes mellitus. Horm Res 1993; 40: 68-79.
36. Wurzburger MI, Sönksen PH. Natural course of growth hormone hypersecretion in insulin-dependent diabetes mellitus. Med Hypotheses 1996; 46: 145-9.